Gotowa bibliografia na temat „Cyclin-dependent kinases”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cyclin-dependent kinases”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Cyclin-dependent kinases"
Sclafani, Robert A. "Cyclin dependent kinase activating kinases." Current Opinion in Cell Biology 8, no. 6 (December 1996): 788–94. http://dx.doi.org/10.1016/s0955-0674(96)80079-2.
Pełny tekst źródłaGitig, Diana M., and Andrew Koff. "Cdk Pathway: Cyclin-Dependent Kinases and Cyclin-Dependent Kinase Inhibitors." Molecular Biotechnology 19, no. 2 (2001): 179–88. http://dx.doi.org/10.1385/mb:19:2:179.
Pełny tekst źródłaMalumbres, Marcos. "Cyclin-dependent kinases." Genome Biology 15, no. 6 (2014): 122. http://dx.doi.org/10.1186/gb4184.
Pełny tekst źródłaHarper, J. W., and P. D. Adams. "Cyclin-Dependent Kinases." Chemical Reviews 101, no. 8 (August 2001): 2511–26. http://dx.doi.org/10.1021/cr0001030.
Pełny tekst źródłaDynlacht, B. D., K. Moberg, J. A. Lees, E. Harlow, and L. Zhu. "Specific regulation of E2F family members by cyclin-dependent kinases." Molecular and Cellular Biology 17, no. 7 (July 1997): 3867–75. http://dx.doi.org/10.1128/mcb.17.7.3867.
Pełny tekst źródłaMalumbres, Marcos, and Mariano Barbacid. "Mammalian cyclin-dependent kinases." Trends in Biochemical Sciences 30, no. 11 (November 2005): 630–41. http://dx.doi.org/10.1016/j.tibs.2005.09.005.
Pełny tekst źródłaClarke, Paul R. "Cyclin-Dependent Kinases: CAK-handed kinase activation." Current Biology 5, no. 1 (January 1995): 40–42. http://dx.doi.org/10.1016/s0960-9822(95)00013-3.
Pełny tekst źródłaFeroche, Alemu Tadesse, and Frehiwot Beyene Woselassie. "A review on macrocyclic kinase inhibitors in clinical trials." International Journal of Pharmaceutical Chemistry and Analysis 11, no. 2 (July 15, 2024): 147–52. http://dx.doi.org/10.18231/j.ijpca.2024.020.
Pełny tekst źródłaWang, Fuhu, Dale Corbett, Hitoshi Osuga, Sachiko Osuga, Joh-E. Ikeda, Ruth S. Slack, Matthew J. Hogan, Antoine M. Hakim, and David S. Park. "Inhibition of Cyclin-Dependent Kinases Improves CA1 Neuronal Survival and Behavioral Performance after Global Ischemia in the Rat." Journal of Cerebral Blood Flow & Metabolism 22, no. 2 (February 2002): 171–82. http://dx.doi.org/10.1097/00004647-200202000-00005.
Pełny tekst źródłaCanavese, Miriam, Loredana Santo, and Noopur Raje. "Cyclin dependent kinases in cancer." Cancer Biology & Therapy 13, no. 7 (May 2012): 451–57. http://dx.doi.org/10.4161/cbt.19589.
Pełny tekst źródłaRozprawy doktorskie na temat "Cyclin-dependent kinases"
Kitsios, Georgios. "Characterization of Arabidopsis cyclin dependent kinases." Thesis, University of East Anglia, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426634.
Pełny tekst źródłaMiller, Matthew P. Ph D. (Matthew Paul) Massachusetts Institute of Technology. "Meiotic regulation of cyclin-dependent kinases." Thesis, Massachusetts Institute of Technology, 2013. http://hdl.handle.net/1721.1/79185.
Pełny tekst źródłaGomes, Felipe Campelo. "Analysis of cyclin dependent kinases in Leishmania." Thesis, University of Glasgow, 2007. http://theses.gla.ac.uk/32/.
Pełny tekst źródłaSecombe, Julie. "Identification of novel G1 to S phase regulators in Drosophila /." Title page, contents and abstract only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phs4448.pdf.
Pełny tekst źródłaCrack, Donna. "Analysis of the function of Drosophila cyclin E isoforms and identification of interactors." Title page, table of contents and abstract only, 2002. http://web4.library.adelaide.edu.au/theses/09PH/09phc8837.pdf.
Pełny tekst źródłaDixon-Clarke, Sarah. "Structure and inhibition of novel cyclin-dependent kinases." Thesis, University of Oxford, 2015. https://ora.ox.ac.uk/objects/uuid:3c6955c9-469a-4f4b-9577-309ccb57b742.
Pełny tekst źródłaSallam, Hatem. "Pharmacological and analytical studies of the cyclin dependent kinase inhibitors." Stockholm, 2009. http://diss.kib.ki.se/2009/978-91-7409-706-1/.
Pełny tekst źródłaAlexiou, Konstantinos G. "Cyclin-dependent kinases and nuclear functions in Arabidopsis thaliana." Thesis, University of East Anglia, 2011. https://ueaeprints.uea.ac.uk/34236/.
Pełny tekst źródłaHenderson, Andrew. "Isosteres of sulfonamide inhibitors of cyclin-dependent kinases (CDKs)." Thesis, University of Newcastle Upon Tyne, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.512187.
Pełny tekst źródłaCheng, Kai. "Identification of Pctaire1 as a p35-interacting protein and a novel substrate for Cdk5 /." View Abstract or Full-Text, 2003. http://library.ust.hk/cgi/db/thesis.pl?BICH%202003%20CHENG.
Pełny tekst źródłaKsiążki na temat "Cyclin-dependent kinases"
Dyson, Nicholas. Abstracts of papers presented at the 2008 meeting on the cell cycle: May 14-May 18, 2008. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 2008.
Znajdź pełny tekst źródłaElledge, Stephen Joseph, and J. Wade Harper. Abstracts of papers presented at the 2002 meeting on the cell cycle, May 15-May 19, 2002. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 2002.
Znajdź pełny tekst źródłaBiggins, Susan, and Nicholas Dyson. Abstracts of papers presented at the 2010 meeting on the cell cycle: May 18-May 22, 2010. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 2010.
Znajdź pełny tekst źródłaB, Kastan M., and Imperial Cancer Research Fund (Great Britain), eds. Checkpoint controls and cancer. Plainview, NY: Cold Spring Harbor Laboratory Press, 1997.
Znajdź pełny tekst źródłaVogt, Peter K., and Steven I. Reed, eds. Cyclin Dependent Kinase (CDK) Inhibitors. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-71941-7.
Pełny tekst źródłaOrzáez, Mar, Mónica Sancho Medina, and Enrique Pérez-Payá, eds. Cyclin-Dependent Kinase (CDK) Inhibitors. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2926-9.
Pełny tekst źródłaIp, Nancy Y., and Li-Huei Tsai, eds. Cyclin Dependent Kinase 5 (Cdk5). Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-78887-6.
Pełny tekst źródłaChen, Ginny. Analysis of Saccharomyces cerevisiae cyclin dependent kinase inhibitor Far1. Ottawa: National Library of Canada, 2003.
Znajdź pełny tekst źródłaTechnologie, Karlsruher Institut für, ed. Phosphorylation and Regulation of the Wnt co-Receptor LRP6 by Cyclin Dependent Kinase 14/Cyclin Y and Tyrosine Kinase Fer. [S.l: s.n.], 2014.
Znajdź pełny tekst źródłaLogan, Angela Berti. Characterization of new alleles of PHO85, a cyclin-dependent kinase of Saccharomyces cerevisiae. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.
Znajdź pełny tekst źródłaCzęści książek na temat "Cyclin-dependent kinases"
Golsteyn, Roy M. "Cyclin-Dependent Kinases." In Encyclopedia of Cancer, 1–4. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_1429-2.
Pełny tekst źródłaGolsteyn, Roy M. "Cyclin-Dependent Kinases." In Encyclopedia of Cancer, 1269–73. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46875-3_1429.
Pełny tekst źródłaMalumbres, Marcos. "Cyclins and Cyclin-dependent Kinases." In Encyclopedia of Systems Biology, 509–12. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-9863-7_10.
Pełny tekst źródłaMeijer, Laurent. "Chemical inhibitors of cyclin-dependent kinases." In Progress in Cell Cycle Research, 351–63. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1809-9_29.
Pełny tekst źródłaLaw, Mary E., and Brian K. Law. "Cyclin-Dependent Kinases as Therapeutic Targets." In Encyclopedia of Molecular Pharmacology, 505–7. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-57401-7_10043.
Pełny tekst źródłaLaw, Mary E., and Brian K. Law. "Cyclin-dependent kinases as therapeutic targets." In Encyclopedia of Molecular Pharmacology, 1–3. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-21573-6_10043-1.
Pełny tekst źródłaKoff, Andrew, and Kornelia Polyak. "p27KIP1, an inhibitor of cyclin-dependent kinases." In Progress in Cell Cycle Research, 141–47. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1809-9_11.
Pełny tekst źródłaLi, Yan, Christopher W. Jenkins, Michael A. Nichols, Xiaoyu Wu, Kun-Liang Guan, and Yue Xiong. "p16 Family Inhibitors of Cyclin-Dependent Kinases." In Cancer Genes, 57–82. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4615-5895-8_4.
Pełny tekst źródłaJohnson, Neil, and Geoffrey I. Shapiro. "Targeting Cyclin-Dependent Kinases for Cancer Therapy." In Cell Cycle Deregulation in Cancer, 167–85. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1770-6_11.
Pełny tekst źródłaBoutros, Rose. "Regulation of Centrosomes by Cyclin-Dependent Kinases." In The Centrosome, 187–97. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-035-9_11.
Pełny tekst źródłaStreszczenia konferencji na temat "Cyclin-dependent kinases"
Surin, Svyatoslav Sergeevich, and G. L. Snigur. "Expression of cyclin-dependent kinases in pancreatic islets during experimental hyperglycemia." In International Research Conference on Technology, Science, Engineering & Management. Seattle: Профессиональная наука, 2021. http://dx.doi.org/10.54092/9781365973192_35.
Pełny tekst źródłaSurin, Svyatoslav Sergeevich, and G. L. Snigur. "Expression of cyclin-dependent kinases in pancreatic islets during experimental hyperglycemia." In International Research Conference on Technology, Science, Engineering & Management. Seattle: Профессиональная наука, 2021. http://dx.doi.org/10.54092/9781365973192_35.
Pełny tekst źródłaДенисова, Дарья Андреевна. "CYCLIN-DEPENDENT KINASES CDK8 / 19 AND THEIR INFLUENCE ON THE ORIGIN AND DEVELOPMENT OF TUMOR PROCESSES." In Наука. Исследования. Практика: сборник избранных статей по материалам Международной научной конференции (Санкт-Петербург, Апрель 2020). Crossref, 2020. http://dx.doi.org/10.37539/srp290.2020.80.21.015.
Pełny tekst źródłaKholmurodov, Kholmirzo T., Yu E. Penionzhkevich, and E. A. Cherepanov. "Computer Molecular Dynamics Studies on Protein Structures (Visual Pigment Rhodopsin and Cyclin-Dependent Kinases)." In INTERNATIONAL SYMPOSIUM ON EXOTIC NUCLEI. AIP, 2007. http://dx.doi.org/10.1063/1.2746628.
Pełny tekst źródłaKunadharaju, R., A. Saradna, M. Ahmad, and G. Fuhrer. "Palbociclib (Cyclin-Dependent Kinases CDK4 and CDK6 Selective Inhibitor) Induced Grade 3 Interstitial Pneumonitis." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2118.
Pełny tekst źródłaSankaranarayanan, Ranjini, Rakesh Dachineni, Siddharth Kesharwani, Ramesh Kumar Dhandapani, Hemachand Tummala, and Jayarama B. Gunaje. "Abstract 4411: Identification of novel natural compounds as potential inhibitors of cyclin dependent kinases." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-4411.
Pełny tekst źródłaSankaranarayanan, Ranjini, Rakesh Dachineni, Siddharth Kesharwani, Ramesh Kumar Dhandapani, Hemachand Tummala, and Jayarama B. Gunaje. "Abstract 4411: Identification of novel natural compounds as potential inhibitors of cyclin dependent kinases." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-4411.
Pełny tekst źródłaFu, Wei, Le Ma, Baoky Chu, Xue Wang, Tapan K. Bagui, Marilyn M. Bui, Jennifer Gemmer, Soner Altiok, Douglas G. Letson, and W. Jack Pledger. "Abstract 3596: SCH727965, a cyclin-dependent kinases inhibitor, induces apoptosis in sarcoma cells through caspase 3- dependent pathway." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3596.
Pełny tekst źródłaRamos Rodríguez, J., S. Hernández Rojas, I. González Perera, MM Viña Romero, GJ Nazco Casariego, FJ Merino Alonso, S. García Gil, B. Del Rosario García, L. Cantarelli, and F. Gutiérrez Nicolás. "5PSQ-059 Cyclin dependent kinases 4/6 inhibitors: new options in hr+ her2- breast cancer." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.492.
Pełny tekst źródłaTien, Amy H., Nasrin R. Mawji, Jun Wang, and Marianne D. Sadar. "Abstract 1000: Targeting androgen receptors and cyclin-dependent kinases 4 and 6 in breast cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-1000.
Pełny tekst źródłaRaporty organizacyjne na temat "Cyclin-dependent kinases"
Wohlschlegel, James, and Anindya Dutta. Development of Inhibitors That Selectively Disrupt Substrate Recognition by Cyclin-Dependent Kinases. Fort Belvoir, VA: Defense Technical Information Center, August 2002. http://dx.doi.org/10.21236/ada410428.
Pełny tekst źródłaDonovan, Joseph. Development and Use of Novel Tools to Directly Screen for Substrates of Cyclin Dependent Kinases. Fort Belvoir, VA: Defense Technical Information Center, August 1999. http://dx.doi.org/10.21236/ada376126.
Pełny tekst źródłaDonovan, Joseph. Development and Use of Novel Tools to Directly Screen for Substrates of Cyclin Dependent Kinases. Fort Belvoir, VA: Defense Technical Information Center, August 2000. http://dx.doi.org/10.21236/ada392561.
Pełny tekst źródłaWilliams, Stephen D. Cyclin Dependent Kinase Inhibitors as Targets in Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 2005. http://dx.doi.org/10.21236/ada446399.
Pełny tekst źródłaWilliams, Stephen D. Cyclin Dependent Kinase Inhibitors as Targets in Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 2002. http://dx.doi.org/10.21236/ada411751.
Pełny tekst źródłaWilliams, Stephen D. Cyclin Dependent Kinase Inhibitors as Targets in Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 2003. http://dx.doi.org/10.21236/ada420941.
Pełny tekst źródłaHarper, J. W. The Role of Cyclin Dependent Kinase Inhibitor, Cip1, in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 1998. http://dx.doi.org/10.21236/ada366917.
Pełny tekst źródłaHarper, J. W. The Role of Cyclin Dependent Kinase Inhibitor, CIP1, in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 1995. http://dx.doi.org/10.21236/ada302399.
Pełny tekst źródłaHarper, J. W. The Role of Cyclin Dependent Kinase Inhibitor, CIP1, in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 1997. http://dx.doi.org/10.21236/ada341520.
Pełny tekst źródłaHarper, J. W. The Role of Cyclin Dependent Kinase Inhibitor, CIP1, in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 1999. http://dx.doi.org/10.21236/ada381538.
Pełny tekst źródła